Index RUT
P/E 108.19
EPS (ttm) 0.43
Insider Own 1.07%
Shs Outstand 48.84M
Perf Week -9.36%
Market Cap 2.29B
Forward P/E 51.72
EPS next Y 0.90
Insider Trans 248.86%
Shs Float 48.34M
Perf Month 21.26%
Income 21.35M
PEG 3.61
EPS next Q 0.05
Inst Own 105.62%
Short Float 10.90%
Perf Quarter 56.47%
Sales 322.42M
P/S 7.09
EPS this Y -39.64%
Inst Trans 1.93%
Short Ratio 7.22
Perf Half Y 6.83%
Book/sh 7.90
P/B 5.92
EPS next Y 48.32%
ROA 4.72%
Short Interest 5.27M
Perf Year -31.42%
Cash/sh 4.52
P/C 10.35
EPS next 5Y 30.00%
ROE 5.95%
52W Range 26.66 - 73.13
Perf YTD 49.86%
Dividend Est. -
P/FCF -
EPS past 5Y 31.51%
ROI 5.11%
52W High -36.05%
Beta 0.80
Dividend TTM -
Quick Ratio 5.08
Sales past 5Y 21.55%
Gross Margin 78.36%
52W Low 75.46%
ATR (14) 2.35
Dividend Ex-Date -
Current Ratio 5.62
EPS Y/Y TTM -45.63%
Oper. Margin 8.71%
RSI (14) 60.55
Volatility 4.78% 5.15%
Employees 1115
Debt/Eq 0.09
Sales Y/Y TTM 13.37%
Profit Margin 6.62%
Recom 1.92
Target Price 49.17
Option/Short Yes / Yes
LT Debt/Eq 0.08
EPS Q/Q 32.91%
Payout 0.00%
Rel Volume 0.52
Prev Close 46.34
Sales Surprise 0.43%
EPS Surprise -27.29%
Sales Q/Q 19.09%
Earnings May 08 AMC
Avg Volume 729.82K
Price 46.77
SMA20 7.53%
SMA50 25.16%
SMA200 19.89%
Trades
Volume 380,627
Change 0.93%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-11-24 Upgrade
Stifel
Hold → Buy
$30 → $50
Dec-05-23 Downgrade
Needham
Buy → Hold
Dec-04-23 Initiated
Morgan Stanley
Equal-Weight
$35
Sep-15-23 Downgrade
The Benchmark Company
Buy → Hold
Aug-03-23 Downgrade
Canaccord Genuity
Buy → Hold
$77 → $48
Jun-07-23 Downgrade
William Blair
Outperform → Mkt Perform
Apr-17-23 Initiated
Piper Sandler
Neutral
$65
Feb-06-23 Downgrade
BTIG Research
Buy → Neutral
Dec-28-22 Reiterated
BTIG Research
Buy
$80 → $67
Dec-08-22 Initiated
Stifel
Hold
$60
Nov-07-22 Upgrade
Sidoti
Neutral → Buy
Oct-14-22 Resumed
Stephens
Overweight
$91
Oct-13-22 Initiated
Mizuho
Buy
$85
Apr-08-22 Initiated
Needham
Buy
$87
Mar-28-22 Upgrade
The Benchmark Company
Hold → Buy
$97
Mar-18-22 Upgrade
BTIG Research
Neutral → Buy
$98
Jul-09-21 Initiated
Oppenheimer
Perform
$150
Jan-19-21 Downgrade
The Benchmark Company
Buy → Hold
Oct-26-20 Downgrade
Sidoti
Buy → Neutral
Aug-31-20 Upgrade
Sidoti
Neutral → Buy
$58
Show Previous Ratings
Apr-05-24 09:15AM
Apr-04-24 04:26PM
(Investor's Business Daily) +16.48%
03:54PM
07:00AM
Apr-02-24 07:00AM
11:45AM
Loading…
Mar-26-24 11:45AM
Mar-20-24 04:22AM
Mar-18-24 07:00AM
Mar-12-24 10:30AM
07:00AM
Mar-06-24 07:00AM
Feb-28-24 10:58AM
Feb-27-24 02:00PM
Feb-26-24 05:30PM
04:39PM
(Associated Press Finance)
04:34PM
Loading…
04:34PM
04:01PM
Feb-19-24 07:00AM
Jan-27-24 01:03PM
Jan-23-24 07:00AM
Jan-12-24 06:49PM
Jan-08-24 07:00AM
Dec-17-23 12:35PM
Dec-05-23 03:16AM
Dec-04-23 04:05PM
Nov-15-23 07:00AM
Nov-02-23 05:50PM
09:23AM
(Thomson Reuters StreetEvents)
Nov-01-23 06:30PM
05:56PM
04:17PM
Loading…
04:17PM
(Associated Press Finance)
04:01PM
Oct-31-23 04:40PM
Oct-18-23 04:05PM
Oct-17-23 07:00AM
Oct-13-23 06:30PM
Oct-10-23 10:51AM
Sep-19-23 11:51AM
Sep-15-23 09:32AM
Sep-14-23 12:53PM
07:00AM
Sep-08-23 11:38AM
Sep-07-23 05:00PM
Aug-18-23 10:40AM
Aug-17-23 06:48PM
Aug-09-23 07:00AM
Aug-07-23 07:00AM
05:00AM
Aug-03-23 07:18PM
Aug-02-23 05:25PM
04:21PM
04:01PM
Jul-19-23 07:00AM
Jun-21-23 08:00PM
Jun-13-23 08:00AM
May-26-23 06:00AM
May-17-23 10:10AM
May-09-23 01:48PM
May-04-23 07:00AM
May-03-23 05:35PM
04:29PM
04:01PM
Apr-27-23 10:02AM
Apr-26-23 08:00PM
10:02AM
Apr-23-23 08:25AM
Apr-19-23 07:00AM
Apr-07-23 11:44AM
Apr-04-23 06:00PM
Mar-29-23 06:00PM
07:00AM
Mar-23-23 06:00PM
Mar-15-23 05:50PM
Mar-13-23 08:48AM
Mar-09-23 05:25AM
Feb-23-23 05:12AM
Feb-21-23 05:15PM
04:01PM
Feb-13-23 05:50PM
Feb-07-23 07:00AM
Feb-03-23 05:50PM
01:58PM
09:00AM
Jan-31-23 09:25AM
Jan-25-23 06:00PM
Jan-24-23 03:26PM
Jan-17-23 06:00PM
Jan-11-23 07:00AM
Jan-10-23 06:41AM
Jan-09-23 07:00AM
Jan-06-23 09:13PM
01:52PM
Dec-30-22 07:17AM
Dec-20-22 08:56AM
Dec-19-22 08:15AM
Dec-13-22 11:01AM
Nov-28-22 01:18PM
Nov-17-22 07:00AM
Nov-13-22 09:28AM
Nov-11-22 08:38AM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
WEISNER AIMEE S Director Mar 14 '24 Buy 38.11 1,750 66,692 10,864 Mar 14 05:23 PM Williams Patrick F. Chief Financial Officer Mar 07 '24 Option Exercise 0.00 2,614 0 45,475 Mar 11 06:06 AM BROADWOOD PARTNERS, L.P. 10% Owner Jan 08 '24 Buy 27.11 4,042 109,570 10,768,430 Jan 10 05:44 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 05 '24 Buy 28.48 156,734 4,463,231 10,764,388 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 04 '24 Buy 28.91 63,246 1,828,183 10,607,654 Jan 05 07:07 PM BROADWOOD PARTNERS, L.P. 10% Owner Jan 03 '24 Buy 28.93 6,573 190,144 10,544,408 Jan 05 07:07 PM Zhou Lilian Yansheng Director Dec 06 '23 Buy 30.74 850 26,129 2,327 Dec 06 04:11 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 30 '23 Buy 31.42 177,707 5,583,678 10,537,835 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 29 '23 Buy 31.39 160,300 5,031,358 10,360,128 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 28 '23 Buy 31.85 96,984 3,088,794 10,199,828 Nov 30 07:08 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 13 '23 Buy 33.04 507 16,749 10,102,844 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 10 '23 Buy 32.73 34,320 1,123,383 10,102,337 Nov 14 07:13 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 09 '23 Buy 33.09 140,000 4,632,581 10,068,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 08 '23 Buy 33.71 139,409 4,699,073 9,928,017 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 07 '23 Buy 34.03 9,731 331,127 9,788,608 Nov 09 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 06 '23 Buy 34.16 164,607 5,623,518 9,778,877 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 03 '23 Buy 36.06 520 18,753 9,614,270 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Nov 02 '23 Buy 35.79 144,027 5,155,243 9,613,750 Nov 06 07:01 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 06 '23 Buy 37.62 75,299 2,832,417 9,469,723 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 05 '23 Buy 37.92 97,474 3,696,399 9,394,424 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Oct 04 '23 Buy 37.93 32,523 1,233,649 9,296,950 Oct 06 07:43 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 21 '23 Buy 39.62 154,814 6,133,467 9,264,427 Sep 21 08:31 PM Lin Elizabeth Yeu Director Sep 21 '23 Buy 40.00 2,500 100,000 2,855 Sep 22 07:18 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 20 '23 Buy 40.67 132,079 5,372,274 9,109,613 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 19 '23 Buy 40.89 4,490 183,613 8,977,534 Sep 21 08:31 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 07 '23 Buy 41.26 60,874 2,511,722 8,973,044 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 06 '23 Buy 41.43 108,944 4,513,735 8,912,170 Sep 07 07:00 PM BROADWOOD PARTNERS, L.P. 10% Owner Sep 05 '23 Buy 41.87 20,144 843,455 8,803,226 Sep 07 07:00 PM Williams Patrick F. Chief Financial Officer Aug 10 '23 Option Exercise 0.00 5,122 0 45,400 Aug 11 06:01 PM WEISNER AIMEE S Director Aug 07 '23 Buy 48.72 2,000 97,440 5,417 Aug 07 04:16 PM Kliman Gilbert H Director Jun 15 '23 Option Exercise 0.00 3,417 0 9,656 Jun 16 08:39 PM WEISNER AIMEE S Director Jun 15 '23 Option Exercise 0.00 3,417 0 3,417 Jun 16 08:37 PM Yu K Peony Director Jun 15 '23 Option Exercise 0.00 1,709 0 2,786 Jun 16 08:35 PM FARRELL STEPHEN C Director Jun 15 '23 Option Exercise 0.00 1,709 0 8,276 Jun 16 08:41 PM Williams Patrick F. Chief Financial Officer Jun 06 '23 Option Exercise 0.00 5,121 0 47,387 Jun 07 04:53 PM Michna Magda Chief Clinical, Regulatory, May 08 '23 Option Exercise 0.00 14,047 0 14,047 May 09 05:26 PM Foust Warren Chief Operating Officer May 08 '23 Option Exercise 0.00 20,331 0 20,331 May 09 05:24 PM
Index -
P/E -
EPS (ttm) -23.74
Insider Own 8.48%
Shs Outstand 8.26M
Perf Week -13.66%
Market Cap 21.17M
Forward P/E -
EPS next Y -1.75
Insider Trans 371.40%
Shs Float 7.57M
Perf Month -14.67%
Income -29.13M
PEG -
EPS next Q -0.66
Inst Own 85.90%
Short Float 2.37%
Perf Quarter -22.66%
Sales 1.50M
P/S 14.11
EPS this Y 14.46%
Inst Trans -33.80%
Short Ratio 3.35
Perf Half Y -16.07%
Book/sh 2.48
P/B 1.03
EPS next Y 26.78%
ROA -
Short Interest 0.18M
Perf Year -57.33%
Cash/sh 1.14
P/C 2.25
EPS next 5Y -
ROE -
52W Range 2.08 - 6.80
Perf YTD 2.40%
Dividend Est. -
P/FCF -
EPS past 5Y 14.72%
ROI -104.79%
52W High -62.35%
Beta 0.79
Dividend TTM -
Quick Ratio 1.49
Sales past 5Y 16.25%
Gross Margin -56.62%
52W Low 23.08%
ATR (14) 0.16
Dividend Ex-Date -
Current Ratio 1.49
EPS Y/Y TTM -81.28%
Oper. Margin -1482.24%
RSI (14) 34.00
Volatility 13.15% 5.16%
Employees 46
Debt/Eq 0.11
Sales Y/Y TTM -
Profit Margin -1938.06%
Recom 1.67
Target Price 4.20
Option/Short No / Yes
LT Debt/Eq 0.09
EPS Q/Q -21.67%
Payout -
Rel Volume 0.69
Prev Close 2.59
Sales Surprise 39.56%
EPS Surprise 61.99%
Sales Q/Q -69.12%
Earnings Apr 12 BMO
Avg Volume 53.52K
Price 2.56
SMA20 -11.81%
SMA50 -13.21%
SMA200 -21.66%
Trades
Volume 36,692
Change -1.16%
Date
Action
Analyst
Rating Change
Price Target Change
May-24-22 Downgrade
Stephens
Overweight → Equal-Weight
Mar-14-22 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jan-07-22 Initiated
Stephens
Overweight
$3.10
Jan-06-22 Resumed
Piper Sandler
Overweight
$3.10
Mar-17-21 Resumed
Needham
Buy
$8
Jan-07-21 Upgrade
The Benchmark Company
Speculative Buy → Buy
$6
Dec-16-20 Upgrade
Piper Sandler
Neutral → Overweight
$2 → $4
Nov-30-20 Initiated
BTIG Research
Buy
$5
Nov-10-20 Initiated
KeyBanc Capital Markets
Overweight
$5
Jul-30-20 Reiterated
The Benchmark Company
Speculative Buy
$7 → $6
Jul-01-20 Downgrade
Piper Sandler
Overweight → Neutral
Jun-30-20 Downgrade
Chardan Capital Markets
Buy → Neutral
$2
Jun-02-20 Initiated
Needham
Buy
$4
Feb-13-19 Initiated
Piper Jaffray
Overweight
$6
Jan-29-19 Upgrade
Janney
Neutral → Buy
Dec-19-18 Resumed
Lake Street
Buy
Show Previous Ratings
Apr-12-24 10:52AM
06:00AM
Apr-11-24 09:46PM
05:30PM
Apr-09-24 04:05PM
08:00AM
Loading…
Jan-16-24 08:00AM
Dec-06-23 08:00AM
Nov-09-23 08:27AM
07:00AM
Nov-03-23 08:30AM
Sep-18-23 08:00AM
Sep-06-23 08:00AM
Aug-28-23 08:30AM
Aug-10-23 07:00AM
Aug-09-23 08:00AM
08:30AM
Loading…
Aug-08-23 08:30AM
Aug-03-23 08:00AM
Jul-25-23 09:08AM
Jul-24-23 01:35PM
Jun-27-23 08:30AM
Jun-01-23 04:15PM
May-11-23 08:00AM
Apr-27-23 04:59PM
Apr-18-23 08:45AM
Apr-12-23 04:15PM
Apr-07-23 08:24AM
Apr-03-23 08:00AM
Mar-31-23 05:00PM
Mar-29-23 04:01PM
Mar-15-23 04:01PM
09:00AM
Loading…
Mar-02-23 09:00AM
Feb-22-23 08:00AM
Dec-16-22 08:19AM
08:00AM
Nov-30-22 06:05PM
06:00PM
Nov-10-22 04:30PM
Oct-27-22 04:01PM
Oct-06-22 08:00AM
Sep-07-22 08:00AM
Aug-31-22 04:01PM
Aug-30-22 04:27PM
Aug-24-22 08:00AM
Aug-10-22 04:05PM
Aug-03-22 04:01PM
Aug-01-22 11:33AM
05:00AM
Jul-27-22 04:01PM
Jul-13-22 08:00AM
Jul-06-22 08:00AM
Jun-22-22 08:00AM
Jun-15-22 07:15AM
May-26-22 05:00PM
May-11-22 04:05PM
May-05-22 08:00AM
Apr-28-22 04:01PM
Apr-27-22 04:30PM
Apr-22-22 09:26AM
Apr-13-22 10:01PM
05:12PM
05:10PM
Apr-11-22 08:00AM
Mar-28-22 08:00AM
Mar-10-22 04:05PM
Mar-01-22 04:05PM
Feb-21-22 07:26AM
Feb-10-22 08:00AM
Jan-18-22 04:05PM
Jan-06-22 09:43AM
Jan-04-22 08:00AM
Dec-09-21 06:00PM
Dec-08-21 08:00AM
Dec-06-21 08:00AM
Dec-02-21 08:00AM
Nov-22-21 06:14AM
Nov-09-21 04:05PM
Nov-04-21 08:00AM
Nov-02-21 03:02PM
Oct-27-21 08:00AM
Oct-26-21 04:05PM
Oct-08-21 09:46AM
Oct-07-21 08:00AM
Sep-30-21 08:00AM
Sep-20-21 11:35AM
08:00AM
Sep-16-21 08:00AM
Sep-13-21 08:00AM
Sep-07-21 04:05PM
Aug-23-21 09:13AM
Aug-18-21 08:49AM
Aug-17-21 08:00AM
Aug-10-21 04:01PM
Aug-09-21 08:00AM
Aug-03-21 03:00PM
Jul-27-21 10:35AM
Jul-08-21 05:34AM
Jun-22-21 08:00AM
Jun-15-21 08:03AM
Jun-03-21 08:00AM
Jun-01-21 08:00AM
OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
BROADWOOD PARTNERS, L.P. 10% Owner Apr 11 '24 Buy 2.92 2,420,000 7,057,688 4,929,066 Apr 15 07:21 PM Arno Andrew Director Apr 11 '24 Buy 2.95 33,898 99,999 69,054 Apr 15 06:02 AM Riggs Josh CEO and President Apr 11 '24 Buy 2.95 3,390 10,000 3,505 Apr 15 06:04 AM KINGSLEY ALFRED D Director Jun 14 '23 Buy 0.21 30,000 6,447 469,111 Jun 15 08:13 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite